Security
NewGenIvf Group Limited Warrants · NIVFW
NIVFWNASDAQWarrantCurrentCIK 1981662Updated Oct 8, 2026
Name history
ASPAC I Mini Acquisition Corp. · through Mar 1, 2024
NIVFW price & chart
Loading TradingView…
NASDAQ:NIVFW on TradingView ↗About the company
NewGenIVF Group Limited is a technology-forward, diversified growth company pursuing opportunities across real estate development, digital asset innovation and reproductive health solutions. The Company operates through NewGenProperty, focused on real estate development projects in Ras Al Khaimah, United Arab Emirates; NewGenDigital, focused on digital asset and decentralized-finance solutions; and NewGenSup, focused on health and longevity products and solutions. NewGenIVF’s legacy business includes IVF and assisted reproductive treatment services across Asia. To learn more, visit www.nivf.global. Information contained on, or accessible through, the Company’s website is not incorporated by reference into this press release.
In the news
No coverage from other publishers is available.
Seeking Alpha
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 32,722,769Source | 3,577,744Source | 1,647,460Source | 2,904,966Source |
| Property, Plant and Equipment, NetUSD | 1,789,110Source | 273,096Source | 162,157Source | 122,673Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 21,415,069Source | — | — | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 758,621Source | 457,740Source | 54,104Source | 27,556Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 166,531Source | 49,245Source | 9,374Source | 13,000Source |
| Inventory, NetUSD | 335,360Source | 80,813Source | 126,264Source | 46,910Source |
| Assets, CurrentUSD | 7,383,571Source | 3,172,745Source | 1,201,456Source | 2,398,623Source |
| Prepaid Expense and Other Assets, CurrentUSD | 503,588Source | 195,446Source | 517,429Source | 70,285Source |
| Operating Lease, Right-of-Use AssetUSD | 504,192Source | 98,570Source | 283,847Source | 383,670Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 6,736,076Source | 5,059,501Source | 1,241,435Source | 2,804,283Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | — | — | 6,981Source | 6,018Source |
| Additional Paid in CapitalUSD | 17,881,176Source | 122,505Source | — | — |
| Retained Earnings (Accumulated Deficit)USD | 8,893,414Source | -985,994Source | -461,351Source | -591,544Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -143,071Source | 18,875Source | -7,288Source | 9,570Source |
| Stockholders' Equity Attributable to ParentUSD | 26,631,519Source | -1,048,614Source | 896,076Source | 563,113Source |
| Additional Paid in Capital, Common StockUSD | — | — | 4,324,834Source | 1,458,941Source |
| Liabilities and EquityUSD | 32,722,769Source | 3,577,744Source | 1,647,460Source | 2,904,966Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 2,366,351Source | 2,720,354Source | 1,122,456Source | 2,555,650Source |
| Operating Lease, Liability, CurrentUSD | 238,105Source | 108,526Source | 207,128Source | 184,651Source |
| Accounts Payable, CurrentUSD | 779,280Source | 1,298,964Source | 172,626Source | 104,651Source |
| Operating Lease, Liability, NoncurrentUSD | 272,359Source | 10,231Source | 118,979Source | 242,187Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -644,826Source | -433,143Source | -490,051Source | -462,430Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 514,169Source | 201,455Source | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 9,728,723Source | -474,101Source | 108,418Source | 135,847Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 188,109Source | 19,502Source | 31,173Source | 100,533Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | 240,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 117,285Source | 39,871Source | -1,166Source | -129,922Source |
| Increase (Decrease) in InventoriesUSD | 254,547Source | -45,451Source | 80,665Source | 7,219Source |
| Increase (Decrease) in Accounts PayableUSD | -519,684Source | 1,126,338Source | 71,362Source | 58,752Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -10,926,056Source | -8,264,074Source | -1,766,135Source | 1,710,901Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -7,559,774Source | -53,045Source | -69,848Source | -94,452Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | 760,000Source | — | — | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | 135,025Source | 53,045Source | 69,848Source | 94,452Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 18,992,758Source | 8,675,790Source | 1,881,493Source | -1,633,781Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 758,621Source | 457,740Source | 54,104Source | 27,556Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 26,206Source | 768,068Source | 24,704Source | 55,469Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -206,047Source | 44,965Source | -18,962Source | 16,124Source |
| Additional Financial Items | ||||
| Amortization of Debt Issuance CostsUSD | — | 281,268Source | — | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | 86,080Source | — | — | — |
| DepreciationUSD | 188,109Source | 19,502Source | 31,173Source | 100,533Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | 456,731Source | — | — | — |
| Gain (Loss) on Disposition of AssetsUSD | -332,480Source | — | — | 114,013Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | -114,013Source |
| Gain (Loss) on Termination of LeaseUSD | — | 13,092Source | — | — |
| General and Administrative ExpenseUSD | 10,493,596Source | 2,781,075Source | 1,259,364Source | 1,094,962Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 0Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | -486,706Source | — | 208,141Source |
| Investment Income, InterestUSD | 2,251Source | 6,953Source | 518Source | 21Source |
| Net Income (Loss) Attributable to ParentUSD | 9,879,408Source | -524,643Source | 130,193Source | 458,667Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -150,685Source | 50,542Source | -21,775Source | -322,820Source |
| Nonoperating Income (Expense)USD | 20,455,184Source | 199,688Source | 66,176Source | -54,717Source |
| Operating ExpensesUSD | 11,682,307Source | 2,987,389Source | 1,639,543Source | 1,139,064Source |
| Proceeds from Issuance of Common StockUSD | 12,620,496Source | — | 192,308Source | — |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 23,708,371Source | 371,666Source | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 4,726,433Source | 5,433,375Source | 5,136,153Source | 5,944,190Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Operating Income (Loss)USD | -10,726,461Source | -1,160,495Source | 42,242Source | 398,705Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 9,728,723Source | -960,807Source | 108,418Source | 343,988Source |
| Income Tax Expense (Benefit)USD | — | -486,706Source | — | 208,141Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -150,685Source | 50,542Source | -21,775Source | -322,820Source |
| Net Income (Loss) Attributable to ParentUSD | 9,879,408Source | -524,643Source | 130,193Source | 458,667Source |
| Earnings Per Share, BasicUSD per share | 214.73Source | -1.32Source | 0.18Source | 0.8Source |
| Earnings Per Share, DilutedUSD per share | 3.04Source | -0.64Source | 0.18Source | 0.8Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 46,009Source | 358,108Source | 615,135Source | 575,930Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 3,250,020Source | 743,323Source | 615,135Source | 575,930Source |
| Additional Financial Items | ||||
| General and Administrative ExpenseUSD | 10,493,596Source | 2,781,075Source | 1,259,364Source | 1,094,962Source |
| Gross ProfitUSD | 955,846Source | 1,826,894Source | 1,681,785Source | 1,537,769Source |
| Interest ExpenseUSD | — | 765,177Source | — | — |
| Interest Expense, DebtUSD | 616,423Source | 778,656Source | 46,179Source | — |
| Investment Income, InterestUSD | 2,251Source | 6,953Source | 518Source | 21Source |
| Nonoperating Income (Expense)USD | 20,455,184Source | 199,688Source | 66,176Source | -54,717Source |
| Operating ExpensesUSD | 11,682,307Source | 2,987,389Source | 1,639,543Source | 1,139,064Source |
| Other IncomeUSD | -8,099Source | 971,391Source | 111,837Source | 23,019Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 23,708,371Source | 371,666Source | — | — |
| Selling and Marketing ExpenseUSD | 1,188,711Source | 206,314Source | 18,030Source | 36,194Source |
Offerings
Registration 333-298442
- Gross proceeds
- 1250000.0
- Net proceeds
- 1150000.0
- Deal price
- 0.07
- Shares
- 17857143
- Offering price
- $0.07
- Ticker
- NIVF
Filing attachments
ea030798001ex99-1.htm · 6-K · 2026-10-07
Exhibit 99.1 NEWGENIVF GROUP LIMITED UNAUDITED CONSOLIDATED BALANCE SHEETS (Stated in US Dollars) June 30, December 31, …
Read attachment ↗ea030715501ex99-1.htm · 6-K · 2026-09-30
Exhibit 99.1 NewGen Announces Pricing of $1.25 Million Public Offering BANGKOK, September 28, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced the pricing of a public offering made on a reasonable best efforts basis with gross proceeds …
Read attachment ↗ea030715501ex99-2.htm · 6-K · 2026-09-30
Exhibit 99.2 NewGen Announces Closing of $1.25 Million Public Offering BANGKOK, September 30, 2026 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (the “Company”), a tech-forward, diversified, multi-jurisdictional high-growth entity transforming industries through innovative solutions across real estate development, digital asset management and reproductive health solutions, today announced the closing of its previously announced public offering made on a reasonable best efforts bas…
Read attachment ↗ea030132501ex4-6.htm · F-1 · 2026-08-20
EX-4.6 3 ea030132501ex4-6.htm FORM OF PRE-FUNDED WARRANT Exhibit 4.6 REGISTERED PRE-FUNDED WARRANT TO PURCHASE CLASS A ORDINARY SHARES NEWGENIVF GROUP LIMITED Warrant Shares: [●] Initial Exercise Date: [●], 2026 Issuance Date: [●], 2026 THIS PRE-FUNDED WARRANT TO PURCHASE ORDINARY SHARES (the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the cond…
Read attachment ↗ea030160101ex99-1.htm · 6-K · 2026-08-17
Exhibit 99.1 NewGenIVF Completes Exchange of Convertible Notes with Institutional Investor Restructuring eliminates prior mandatory proceeds sweep and improves capital structure flexibility BANGKOK, August 17, 2026 - NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today announced that it has completed an exchange agreement with a certain institutional investor (“Investor”) pursuant to which existing convertible notes held by…
Read attachment ↗ea029980301ex99-1.htm · 6-K · 2026-07-30
Exhibit 99.1 NewGen Provides Update on K25.ai Investment and Strengthened Financial Position NewGen’s total shares outstanding count expected to reach 5.9 million following recently announced share issuance, bolstering market capitalization NewGen’s agreed 13% stake in K25.ai is now valued at approximately US$26 million, based on K25.ai’s recently closed Series A investment round, representing an unrealized gain of about US$8.5 million BANGKOK, July 30, 2026 - NewGenIVF Group Limited (Nasdaq…
Read attachment ↗